Low-Dose Mycophenolate Mofetil for Treatment of Neuromyelitis Optica Spectrum Disorders: A Prospective Multicenter Study in South China

Objective: To evaluate the efficacy and safety of low-dose mycophenolate mofetil (MMF, 1,000 mg/day) treatment of neuromyelitis optica spectrum disorders (NMOSDs).Methods: This study was a multicenter, open, prospective, follow-up clinical trial. The data include retrospective clinical data from the...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Qiao Huang, Jingqi Wang, Yifan Zhou, Hui Yang, Zhanhang Wang, Zhenwen Yan, Youming Long, Jia Yin, Huiyu Feng, Caixia Li, Zhengqi Lu, Xueqiang Hu, Wei Qiu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2018-09-01
coleção:	Frontiers in Immunology
Assuntos:	neuromyelitis optica spectrum disorders mycophenolate mofetil therapy a prospective study South China
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fimmu.2018.02066/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!